Welcome to our dedicated page for Philip Morris International news (Ticker: PM), a resource for investors and traders seeking the latest updates and insights on Philip Morris International stock.
Philip Morris International Inc. reports developments across its cigarette business and expanding smoke-free portfolio, including IQOS heated tobacco products, ZYN nicotine pouches and e-vapor offerings. Company news commonly covers quarterly results, shipment and revenue trends, product authorizations, brand collaborations, and updates tied to adult-smoker alternatives.
Recurring announcements also address U.S. and international regulatory matters, including FDA modified-risk tobacco product authorizations for IQOS, as well as annual shareholder meetings, board elections, executive compensation votes, auditor ratification, shareholder proposals, and corporate responsibility initiatives.
Philip Morris International (NYSE: PM) has opened its new Aurora, Colorado manufacturing campus, representing approximately $1.2 billion in planned capital expenditures between 2024 and 2028, with about $1 billion invested to date. The 780,000-square-foot, 148-acre site is PMI’s first greenfield manufacturing complex in the U.S. and began commercial production in July 2026, manufacturing ZYN nicotine pouches.
The integrated campus combines production, packaging, warehousing, and distribution, supporting U.S. supply and future exports across Asia, Latin America, and the Caribbean. PMI U.S. expects to employ about 500 workers at the facility. An economic impact study projected nearly $1 billion in construction-related impact, and, once fully operational, about $550 million in annual economic impact and 1,000 indirect jobs. The opening follows the June 30, 2026 U.S. FDA authorization of 20 ZYN products as modified risk tobacco products.
Philip Morris International (NYSE: PM) reported Q2 2026 net revenues up 10.4% (7.6% organically) to $11.2 billion, with smoke-free up 11.7% and combustibles up 9.5%. Smoke-free products contributed about 42% of net revenues, and group shipment volume grew 2.5%.
Q2 gross profit rose 11.5% to $7.7 billion and operating income increased 22.0% to $4.5 billion. Reported diluted EPS declined 7.7% to $1.80, mainly due to a non-cash $511 million impairment of the RBH equity investment, while adjusted diluted EPS increased 15.2% to $2.20 (13.6% excluding currency). For the first six months, net revenues grew 9.8% to $21.3 billion and adjusted diluted EPS rose 15.6% to $4.16.
According to PMI, 2026 adjusted diluted EPS is now forecast at $8.26, implying 9.5%–11.5% growth versus 2025, or $8.11 excluding a $0.15 currency benefit, up 7.5%–9.5%.
Philip Morris International (NYSE: PM) will host a live audio webcast on Wednesday, July 22, 2026, at 9:00 a.m. ET to discuss its 2026 second-quarter and first six-months financial results, which will be released at about 7:00 a.m. ET the same day.
The listen-only webcast, led by CFO Emmanuel Babeau and incoming Group CFO Massimo Andolina, will feature a Q&A with the investment community and be accessible via PMI’s website and Investor Relations app. A recording, slides and script will be available for one year.
PMI highlights that smoke-free products represented 43% of its Q1 2026 total net revenues and, as of December 31, 2025, were used by an estimated 43 million legal-age consumers in over 105 markets. PMI reports investing over $16 billion since 2008 in developing and commercializing smoke-free products and notes multiple U.S. FDA marketing and Modified Risk Tobacco Product authorizations for IQOS devices, consumables, General snus and ZYN nicotine pouches.
Philip Morris International (NYSE:PM) announced the ZYN America250 Art Series, a nationwide cultural initiative from the ZYN nicotine pouch brand marking America's 250th anniversary. Selected American and U.S.-based artists will create original works adapted into collectible, limited-edition metal ZYN cases.
The empty accessory cases will debut for ZYN Rewards members, then expand via ecommerce and select retailers through 2026 as part of PMI U.S.'s broader America250 cultural and community programming.
Philip Morris International (NYSE: PM) received U.S. FDA Modified Risk Tobacco Product (MRTP) orders for 20 ZYN nicotine pouch variants, the first nicotine pouches with such authorization.
FDA authorized marketing the claim that using ZYN instead of cigarettes lowers risk of several smoking-related diseases, following earlier PMTA authorization in January 2025.
Philip Morris International U.S. (NYSE:PM) released Harris Poll findings showing Americans support innovation that delivers tangible local benefits. While 76% say innovation is key to the nation’s future, 79% believe the country is innovating in the wrong areas and 81% see corporate rhetoric as disconnected from real problems.
Respondents prioritize affordability, healthcare access, housing, and good local jobs, and prefer companies that act as long-term community partners. PMI U.S. highlights over $1 billion invested in U.S. manufacturing and operations since 2022 and a workforce of more than 3,300 employees.
Philip Morris International (NYSE:PM) and Maestro Andrea Bocelli launched “Believe. Further”, a multi-year platform to foster dialogue on progress and positive change across Europe. The initiative aligns Bocelli’s personal journey with PMI’s business transformation.
Smoke-free products generated 43% of PMI’s Q1 2026 net revenues, reaching over 43 million legal-age consumers in more than 105 markets. Since 2008, PMI has invested over $16 billion in smoke-free innovation and scientific assessment, and the FDA has authorized marketing and modified-risk claims for certain IQOS, General snus, and ZYN products.
Philip Morris International (NYSE:PM) has been named to the WSJ Leadership Institute’s inaugural “Best Companies for the Future” ranking, placing #97 overall and third in the Food Beverage & Tobacco group.
PMI highlights its smoke-free transformation: smoke-free products in over 105 markets, serving an estimated 43 million adults, generating 43% of Q1 2026 net revenues and supported by over $16 billion invested since 2008 and multiple FDA authorizations.
Philip Morris International (NYSE: PM) and WSJ Intelligence released topline findings of a global study on the growing value of human cognition in an AI-driven workplace. Surveying 2,500 professionals across five countries, the research highlights a “Human Premium” on skills such as creative empathy, critical thinking and ethical judgment.
Key insights include an AI trust gap, risks of cognitive atrophy from overreliance on automation, and a seniority divide in AI proficiency. PMI also underscores its broader transformation, with smoke-free products contributing 43% of first-quarter 2026 net revenues and over $16 billion invested in smoke-free innovation since 2008.
Philip Morris International (NYSE: PM) announced new regional presidents effective August 1, 2026: Marco Hannappel for Europe and Can Kuterdem for Latin America & Canada. They join Gijs de Best and Vassilis Gkatzelis as four regional leaders reporting to PMI International CEO Frederic de Wilde.
PMI highlights progress toward a smoke-free portfolio: smoke-free products represented 43% of first-quarter 2026 net revenues and were used by over 43 million legal-age consumers as of December 31, 2025, following more than $16 billion invested since 2008.